Last updated: 2026-09-16 10:32:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
CorMedix Inc. (CRMD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $7.75, with a market capitalisation of $614.98M and a P/E ratio of 3.23. Over the past 52 weeks, its price has ranged from $6.13 to $13.02. This page covers its latest market performance, valuation, price trends and company information.
$614.98M | |
$7.71 | |
$52.00 | |
$0.73 | |
$7.76 | |
317.00 | |
1.25M | |
3.23 | |
$13.02 | |
$6.13 | |
-- | |
-- |
CorMedix Inc. (CRMD) is trading at $7.75 in pre-market trading as of 2026-09-16 10:30:00, down 0.19% ($0.01) from the previous close of $7.76
Pre-market trading shows how investors are pricing CRMD before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, CorMedix Inc. (CRMD) moved from $8.43 to $7.75, representing a decline of 8.13% ($0.68).
The stock traded between $7.66 and $8.61 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 877.07 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 23.5%
CRMD is currently trading at $7.75, placing it 23.5% of the way from its 52-week low of $6.13 to its 52-week high of $13.02. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 191 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of CorMedix Inc. (CRMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.